Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Tretazicar

EU orphan designation number: EU/3/08/529   
Active ingredient: Tretazicar
Indication: Treatment of visceral leishmaniasis
Sponsor: Morvus Technology Limited
Llanvetherine Court, Llanvetherine, Abergavenny NP7 8NL, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/02/2008 Orphan Designation EMEA/OD/095/07 (2008)498 of 04/02/2008
15/08/2011 Corrigendum (2011)5933 of 10/08/2011
26/06/2013 Change of address of sponsor